United Therapeutics: Family trust sells 5,410 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
A family trust in which United Therapeutics Chairperson & CEO Martine A. Rothblatt shares investment power exercised options for 5,410 common shares at $117.76 per share on November 18, 2026. The trust then sold 5,410 resulting shares in 15 reported transactions at reported per-share prices from $570.8167 to $586.7350. The exercise and sales were the final trades under a pre-arranged 10b5-1 trading plan adopted November 7, 2025.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option F1, F20, F21 | 5,410 | $0.00 | $0.00 |
| Exercise | Common Stock F1, F2 | 5,410 | $117.76 | $637K |
| Sale | Common Stock F1, F3, F2 | 120 | $570.8167 | $68K |
| Sale | Common Stock F1, F4, F2 | 80 | $571.6344 | $46K |
| Sale | Common Stock F1, F5, F2 | 140 | $573.3994 | $80K |
| Sale | Common Stock F1, F6, F2 | 259 | $574.3561 | $149K |
| Sale | Common Stock F1, F7, F2 | 201 | $575.2647 | $116K |
| Sale | Common Stock F1, F8, F2 | 440 | $576.6525 | $254K |
| Sale | Common Stock F1, F9, F2 | 909 | $577.5944 | $525K |
| Sale | Common Stock F1, F10, F2 | 838 | $578.5862 | $485K |
| Sale | Common Stock F1, F11, F2 | 628 | $579.5538 | $364K |
| Sale | Common Stock F1, F12, F2 | 420 | $580.7628 | $244K |
| Sale | Common Stock F1, F13, F2 | 696 | $581.7941 | $405K |
| Sale | Common Stock F1, F14, F2 | 439 | $582.8031 | $256K |
| Sale | Common Stock F1, F15, F2 | 123 | $583.7361 | $72K |
| Sale | Common Stock F1, F16, F2 | 77 | $584.949 | $45K |
| Sale | Common Stock F1, F2 | 40 | $586.735 | $23K |
| Holding | Common Stock | -- | -- | -- |
| Holding | Common Stock | -- | -- | -- |
| Holding | Common Stock F17 | -- | -- | -- |
| Holding | Common Stock F18 | -- | -- | -- |
| Holding | Common Stock F19 | -- | -- | -- |
Footnotes (21)
- F1. This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. The transactions reported on this Form 4 are the final trades under this plan.
- F10. This transaction was executed in multiple trades at prices ranging from $578.15 to $579.11. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F11. This transaction was executed in multiple trades at prices ranging from $579.16 to $579.92. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F12. This transaction was executed in multiple trades at prices ranging from $580.37 to $581.30. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F13. This transaction was executed in multiple trades at prices ranging from $581.39 to $582.37. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F14. This transaction was executed in multiple trades at prices ranging from $582.43 to $583.38. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F15. This transaction was executed in multiple trades at prices ranging from $583.72 to $584.38. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F16. This transaction was executed in multiple trades at prices ranging from $584.885 to $585.03. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F17. Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- F18. Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
- F19. Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- F2. Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
- F20. These stock options vested in equal one-third installments on March 15, 2021, 2022 and 2023.
- F21. Stock options held in a family trust as to which the Reporting Person shares investment power and the Reporting Person and immediate family members are beneficiaries.
- F3. This transaction was executed in multiple trades at prices ranging from $570.49 to $571.28. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4. This transaction was executed in multiple trades at prices ranging from $571.53 to $571.76. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5. This transaction was executed in multiple trades at prices ranging from $572.82 to $573.76. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6. This transaction was executed in multiple trades at prices ranging from $573.89 to $574.86. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F7. This transaction was executed in multiple trades at prices ranging from $574.91 to $575.77. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F8. This transaction was executed in multiple trades at prices ranging from $576.09 to $576.91. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F9. This transaction was executed in multiple trades at prices ranging from $577.15 to $578.03. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Key Figures
Key Terms
10b5-1 trading plan regulatory
weighted average price financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What UTHR options did the family trust associated with Martine A. Rothblatt exercise?
AI-generated analysis. How Rhea-AI works. Not financial advice.